Business Context and Reporting Period
CareDx, Inc. filed this Form 8-K on April 17, 2018, to report the entry into a Material Definitive Agreement. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transaction Details
- Debt Financing: Entered into a Credit Agreement for an initial Tranche A Term Loan of $15.0 million, funded on April 17, 2018.
- Optional Financing: A Tranche B Term Loan of $10.0 million is available at the company's option until April 17, 2019, subject to revenue targets and conditions.
- Interest Rate: The loan accrues interest at 9.00% plus the greater of one-month LIBOR or 1.5%.
- Repayment Terms: Interest-only payments until the first principal payment is due on the last day of the first calendar month following April 17, 2021. The loan matures on April 17, 2023.
- Equity Component: Issued a warrant to purchase up to 140,000 shares of common stock at an exercise price of $8.60. An additional warrant for 93,333 shares is contingent on funding Tranche B.
- Collateral: The loan is secured by substantially all company assets and a pledge of 65% of the equity interests of CareDx International AB.
- Fees: Paid a $262,500 fee to the administrative agent for Tranche A. Tranche B would incur a 1.75% fee.
Material Changes and Use of Proceeds
The filing represents a significant change in the company's capital structure through the addition of secured debt. Proceeds from the Tranche A Term Loan are designated for:
- Repayment of outstanding indebtedness with FastPartner AB, Mohammed Al Amoudi, and Danske Bank A/S.
- General corporate purposes.
Outlook, Risks, and Covenants
The Credit Agreement includes customary affirmative and restrictive covenants, including limitations on indebtedness, liens, acquisitions, and dividends. The agreement contains standard events of default, such as nonpayment, bankruptcy, or failure to comply with covenants. Upon an event of default, the interest margin automatically increases by 3.00% per annum, and the lender may declare all obligations immediately due and payable. The Tranche B loan is contingent on the company achieving certain product revenue targets.
Investor Verification Checklist
- Verify the specific amount of outstanding indebtedness with FastPartner AB, Mohammed Al Amoudi, and Danske Bank A/S that was repaid.
- Review the specific product revenue targets required to access the $10.0 million Tranche B Term Loan.
- Confirm the impact of the 9.00% plus LIBOR interest rate on future cash flow projections.
- Assess the implications of pledging 65% of CareDx International AB equity interests on future strategic flexibility.
- Monitor compliance with the restrictive covenants regarding additional indebtedness and asset sales.